University of Oklahoma expands oncology faculty recruitment with open-rank search
The University of Oklahoma Health Sciences Center has opened a search for assistant, associate, and full professor appointments in its newly established Department of Oncology Science. The positions sit within the College of Medicine and are linked to the NCI-designated OU Health Stephenson Cancer Center, giving the new hires access to cancer center resources and interdisciplinary research opportunities.
This is a broad faculty recruitment, but it is also a statement about institutional priorities. The department is seeking investigators whose work spans cancer metabolism, cancer signaling, epigenetics, tumor immunology, and chemical biology. Candidates with cancer biology programs that intersect with diabetes, aging, and neurosciences are also invited to apply, signaling a deliberate effort to build research programs that extend beyond a single molecular silo.
Recruitment priorities center on mechanistic cancer science
The advertised search favors scientists able to run independent programs and compete at the level expected for biomedical faculty in a research-intensive setting. A PhD, MD, or MD/PhD in a biomedical field is required. A strong publication record in high-impact journals is expected, and applicants with NCI funding are especially encouraged.
The scientific themes give a clear picture of the department’s intended identity. Cancer metabolism and signaling remain central because both pathways govern proliferation, survival, and treatment resistance. Epigenetic dysregulation can reprogram tumor behavior without altering the DNA sequence itself, while tumor immunology is now inseparable from modern oncology because immune evasion shapes both disease progression and therapeutic response. Chemical biology, in turn, offers the translational tools needed to probe druggable pathways and refine target validation before clinical development.
A separate sentence belongs here because the practical stakes are obvious. The department is recruiting people who can build programs, not only publish papers.
Five years of startup support and salary review will be individualized
The posting says selected candidates will receive competitive salaries and startup support for a period of five years. Both the salary and startup package will be determined through committee recommendation and review of the candidate’s planned research and goals. No fixed dollar amount is listed, so the offer is structured around individual scholarly need rather than a uniform package.
That structure matters for early-stage laboratory building. Five years of startup support can shape whether a researcher can launch the assays, personnel, and infrastructure needed for a serious cancer biology program. For investigators working in technically demanding fields such as epigenetics or chemical biology, those resources often determine how quickly a lab can move from concept to publication and, eventually, to collaborative translational work.
The appointment is expected to begin as early as 2027, and review of applications will start immediately and continue until the roles are filled. In other words, the search is open now, but it is not open-ended.
Interdisciplinary breadth extends beyond oncology alone
The recruitment language does more than enumerate laboratory specialties. By explicitly inviting cancer biology researchers whose work interfaces with diabetes, aging, and neurosciences, the department is signaling interest in the biology of systemic disease interactions. Those overlaps are clinically relevant because tumor behavior does not unfold in isolation from host physiology. Metabolic disease can alter inflammatory tone, aging can affect immune surveillance and tissue repair, and neurobiologic pathways can influence both symptom burden and treatment tolerance.
For faculty candidates, this widens the scope of what may be considered competitive scholarship. The center appears to value research that can connect molecular mechanisms with broader biologic context, particularly where those links may generate new therapeutic hypotheses or collaborative studies.
Application materials emphasize research direction and teaching
Applicants are asked to submit a complete curriculum vitae, a 3-page research plan covering the next 3 to 5 years, a teaching statement of up to 2 pages, and 3 to 5 professional references with email addresses and phone numbers. Materials must be submitted in PDF format by email to the designated contact listed in the posting.
The required research plan is especially revealing. A short- to mid-term scientific roadmap forces candidates to show that their program is not only productive but also coherent, fundable, and aligned with the department’s priorities. The teaching statement signals that the university expects faculty hires to contribute to academic training as well as laboratory leadership.
This is an open-rank search, so the institution is not limiting itself to one career stage. Assistant, associate, and full professors are all eligible, which gives the department room to recruit rising investigators as well as established scientists with larger portfolios and grant support.
Institutional setting and faculty expectations are tightly aligned
The faculty will be affiliated with the OU Health Stephenson Cancer Center, an NCI-designated center that adds a recognized cancer research environment to the academic appointment. That affiliation is likely to appeal to investigators who want access to collaborative networks, shared resources, and a clinical research ecosystem capable of supporting translational work.
The requirements point to a role that blends scholarship, mentorship, and research leadership. Applicants are expected to demonstrate the capacity to manage an independent research program, which implies responsibility for funding strategy, team building, and ongoing scientific output. In a new department, those responsibilities carry extra weight because early hires often shape the culture, direction, and external reputation of the unit.
The recruitment is explicit about its scientific ambitions, but it leaves the usual institutional variables open: exact compensation, exact startup size, and final rank will depend on the candidate and committee review. For prospective faculty, those details will likely be decided during the interview process, where selected candidates will present their research and future goals.